SEARCH

SEARCH BY CITATION

References

  • Bessos, H., Killie, M.K., Seghatchian, J., Skogen, B. & Urbaniak, S.J. (2009) The relationship of anti-HPA-1a amount to severity of neonatal alloimmune thrombocytopenia – Where does it stand? Transfusion and Apheresis Science, 40, 7578.
  • British Paediatric Surveillance Unit (2004) British Paediatric Surveillance Unit. Available at:http://bpsu.inopsu.com/. Accessed 20 July 2010.
  • Bussel, J. (2009) Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. Journal of Thrombosis and Haemostasis, 7(Suppl. 1), 253257.
  • Davoren, A., McParland, P., Barnes, C.A. & Murphy, W.G. (2002) Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases. Journal of Clinical Pathology, 55, 289292.
  • Dreyfus, M., Kaplan, C., Verdy, E., Schlegel, N., Durand-Zaleski, I. & Tchernia, G. (1997) Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood, 89, 44024406.
  • General Register Office for Scotland (2007) Scotland’s Population 2006: The Registrar General's Annual Review of Demographic Trends. General Register Office for Scotland, Edinburgh.
  • General Registers Office (2008) Scotland’s Population 2007: The Registrar General’s Annual Review of Demographic Trends. General Register Office for Scotland, Edinburgh.
  • General Registers Office (2009) Scotland’s Population 2008: The Registrar General’s Annual Review of Demographic Trends. General Register Office for Scotland, Edinburgh.
  • Hook, E.B. & Regal, R.R. (1995) Capture-recapture methods in epidemiology: methods and limitations. Epidemiologic Reviews, 17, 243264.
  • INOSS (2010) The International Network of Obstetric Survey Systems. Available at: http://www.npeu.ox.ac.uk/inoss. Accessed 23 June 2010.
  • Kamphuis, M.M., Paridaans, N., Porcelijn, L., De Haas, M., van der Schoot, C.E., Brand, A., Bonsel, G.J. & Oepkes, D. (2010) Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. British Journal of Obstetrics and Gynaecology, 117(11): 133543.
  • Kjeldsen-Kragh, J., Killie, M.K., Tomter, G., Golebiowska, E., Randen, I., Hauge, R., Aune, B., Oian, P., Dahl, L.B., Pirhonen, J., Lindeman, R., Husby, H., Haugen, G., Gronn, M., Skogen, B. & Husebekk, A. (2007) A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood, 110, 833839.
  • Knight, M., Kurinczuk, J.J., Tuffnell, D. & Brocklehurst, P. (2005) The UK Obstetric Surveillance System for rare disorders of pregnancy. British Journal of Obstetrics and Gynaecology, 112, 263265.
  • Murphy, M.F. & Bussel, J.B. (2007) Advances in the management of alloimmune thrombocytopenia. British Journal of Haematology, 136, 366378.
  • Murphy, M.F., Williamson, L.M. & Urbaniak, S.J. (2002) Antenatal screening for fetomaternal alloimmune thrombocytopenia: should we be doing it? Vox Sanguinis, 83(Suppl. 1), 409416.
  • Northern Ireland Statistics and Research Agency (2009) Registrar General Annual Report 2008. Northern Ireland Statistics and Research Agency, Belfast.
  • Office for National Statistics (2008) Birth Statistics 2006 Series FM1 No.35. Office for National Statistics, Newport.
  • Office for National Statistics (2009) Birth Statistics 2007 Series FM1 No.36. Office for National Statistics, Newport.
  • Office for National Statistics (2010) Birth Statistics 2008 Series FM1 No.37. Office for National Statistics, Newport.
  • Radder, C.M., de Haan, M.J., Brand, A., Stoelhorst, G.M., Veen, S. & Kanhai, H.H. (2004) Follow up of children after antenatal treatment for alloimmune thrombocytopenia. Early Human Development, 80, 6576.
  • Rayment, R., Kooij, T.W., Zhang, W., Siebold, C., Murphy, M.F., Allen, D., Willcox, N. & Roberts, D.J. (2009) Evidence for the specificity for platelet HPA-1a alloepitope and the presenting HLA-DR52a of diverse antigen-specific helper T cell clones from alloimmunized mothers. Journal of Immunology, 183, 677686.
  • Regal, R.R. & Hook, E.B. (1984) Goodness-of-fit based confidence intervals for estimates of the size of a closed population. Statistics in Medicine, 3, 287291.
  • Serrarens-Janssen, V.M., Steegers, E.A., van den Bos, A., van Heijst, A.F., Pereira, R. & Semmekrot, B.A. (2005) Experiences with fetomaternal alloimmune thrombocytopenia in the Netherlands over a 2-year period. Acta Obstetrica et Gynecologica Scandinavica, 84, 203.
  • Tiller, H., Killie, M.K., Skogen, B., Oian, P. & Husebekk, A. (2009) Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme. British Journal of Obstetrics and Gynaecology, 116, 594598.
  • Tilling, K., Sterne, J.A. & Wolfe, C.D. (2001) Estimation of the incidence of stroke using a capture-recapture model including covariates. International Journal of Epidemiology, 30, 13511359; discussion 1359–1360.
  • Turner, M.L., Bessos, H., Fagge, T., Harkness, M., Rentoul, F., Seymour, J., Wilson, D., Gray, I., Ahya, R., Cairns, J. & Urbaniak, S. (2005) Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion, 45, 19451956.
  • UK National Screening Committee (2010) Criteria for Appraising the Viability, Effectiveness and Appropriateness of a Screening Programme. Available at: http://www.screening.nhs.uk/criteria. Accessed 19 October 2010.
  • Ward, M.J., Pauliny, J., Lipper, E.G. & Bussel, J.B. (2006) Long-term effects of fetal and neonatal alloimmune thrombocytopenia and its antenatal treatment on the medical and developmental outcomes of affected children. American Journal of Perinatology, 23, 487492.
  • Williamson, L.M., Hackett, G., Rennie, J., Palmer, C.R., Maciver, C., Hadfield, R., Hughes, D., Jobson, S. & Ouwehand, W.H. (1998) The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood, 92, 22802287.